144 related articles for article (PubMed ID: 14575377)
1. The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors.
Yapar Z; Kibar M; Yapar AF; Uguz A; Ozbarlas S; Gonlusen G
Ann Nucl Med; 2003 Sep; 17(6):443-9. PubMed ID: 14575377
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-tetrofosmin scintigraphy in musculoskeletal tumours: the relationship between P-glycoprotein expression and tetrofosmin uptake in malignant lesions.
Yapar Z; Kibar M; Ozbarlas S; Yapar AF; Uguz A; Zorludemir S; Herdem M
Nucl Med Commun; 2002 Oct; 23(10):991-1000. PubMed ID: 12352598
[TBL] [Abstract][Full Text] [Related]
3. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
4. 99mTc tetrofosmin scintigraphy in acute leukaemia: the relationship between marrow uptake of tetrofosmin and P-glycoprotein and chemotherapy response.
Sükan A; Yapar Z; SAhin B; Kara O; Fuat Yapar A; CEtiner S; Kibar M
Nucl Med Commun; 2004 Aug; 25(8):777-85. PubMed ID: 15266171
[TBL] [Abstract][Full Text] [Related]
5. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
[TBL] [Abstract][Full Text] [Related]
6. The value of Tc-99m tetrofosmin scintimammography in the assessment of P-glycoprotein in patients with breast cancer.
Silov G; Erdoğan Z; Özdal A; Tutuş A; Tekin Y; Karaman H; Turhal Ö
Hell J Nucl Med; 2013; 16(3):218-22. PubMed ID: 24137583
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
8. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.
Kuo TH; Liu FY; Chuang CY; Wu HS; Wang JJ; Kao A
Nucl Med Biol; 2003 Aug; 30(6):627-32. PubMed ID: 12900288
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of technetium-99m tetrofosmin liver imaging to detect hepatocellular carcinoma and related to expression of P-glycoprotein or multidrug resistance associated protein-a preliminary report.
Ding HJ; Huang WT; Tsai CS; Chang CS; Kao A
Nucl Med Biol; 2003 Jul; 30(5):471-5. PubMed ID: 12831984
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
Degirmenci B; Kilinc O; Cirak KA; Capa G; Akpinar O; Halilcolar H; Durak H; Akkoclu A; Derebek E; Ucan ES
J Nucl Med; 1998 Dec; 39(12):2116-20. PubMed ID: 9867153
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the P-glycoprotein expression by 99mTc-MIBI bone marrow imaging in patients with untreated leukaemia.
Ak I; Aslan V; Vardareli E; Gülbaş Z
Nucl Med Commun; 2003 Apr; 24(4):397-402. PubMed ID: 12673168
[TBL] [Abstract][Full Text] [Related]
12. Predicting multidrug resistance-related protein and P-glycoprotein expression with technetium-99m tetrofosmin mammoscintigraphy.
Liu TJ; Shiau YC; Tsai SC; Wang JJ; Ho ST; Kao A
Breast; 2003 Feb; 12(1):58-62. PubMed ID: 14659356
[TBL] [Abstract][Full Text] [Related]
13. Single-shot cardiorenal scintigraphy with 99mTc-tetrofosmin: a dynamic characterization at rest and during adenosine infusion.
Fommei E; Bruselli L; Ripoli A; Gimelli A; Ghione S; Giorgetti A; Kush A; Tagliavia ID; Passino C; Marzullo P
J Nucl Med; 2009 Aug; 50(8):1288-95. PubMed ID: 19617333
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between 99m Tc-tetrofosmin uptake and P-glycoprotein expression in non-small-cell lung cancer].
Tabuenca MJ; Vargas JA; Varela A; Salas C; Durántez A; Ortiz Berrocal J
Rev Esp Med Nucl; 1998; 17(6):427-34. PubMed ID: 9873130
[TBL] [Abstract][Full Text] [Related]
15. Detecting parathyroid adenoma using technetium-99m tetrofosmin: comparison with P-glycoprotein and multidrug resistance related protein expression--a preliminary report.
Shiau YC; Tsai SC; Wang JJ; Ho ST; Kao A
Nucl Med Biol; 2002 Apr; 29(3):339-44. PubMed ID: 11929704
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
17. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
[TBL] [Abstract][Full Text] [Related]
18. Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines.
Rodrigues M; Kalinowska W; Zielinski C; Sinzinger H
Nucl Med Commun; 2001 Jun; 22(6):645-50. PubMed ID: 11403175
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
Moustafa H; Riad R; Omar W; Zaher A; Ebied E
Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R
Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]